Targeted radiation boost aims to extend lung cancer control
NCT ID NCT06627738
Summary
This study is testing whether adding a precise, high-dose radiation treatment (called CyberKnife) after standard chemotherapy and radiation helps people with advanced non-small cell lung cancer live longer without their cancer getting worse. It will involve 42 patients who have already completed the initial treatment. Researchers will track if the extra treatment improves survival and quality of life over two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Antoine Lacassagne
RECRUITINGNice, 06000, France
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.